MAPS Welcomes Liana Gillooly and Andrew “Mo” Septimus to Board of Directors
May 7, 2026
SAN JOSE, CA; May 7, 2026 — The Multidisciplinary Association for Psychedelic Studies (MAPS) today announced the addition of Liana Sananda Gillooly and Andrew “Mo” Septimus to its Board of Directors. …
MAPS & State of Colorado Partner to Deliver Free Harm Reduction Training for First Responders
May 5, 2026
DENVER, May 5, 2026 — The Multidisciplinary Association for Psychedelic Studies (MAPS) announced a partnership with the Colorado Department of Revenue’s Natural Medicine Division to provide MAPS’ …
MAPS Statement on Bipartisan Congressional Letter to FDA
May 4, 2026
Washington DC — Reps. Jack Bergman (R-MI) and Lou Correa (D-CA), co-chairs of the Congressional Psychedelics Advancing Therapies Caucus, led a bipartisan group of 30 members of Congress in a letter to …
MAPS Celebrates 40 Years at a Defining Moment for Psychedelics
April 23, 2026
April 22, 2026 — Forty years ago, Rick Doblin, Ph.D., incorporated the Multidisciplinary Association for Psychedelic Studies (MAPS) as a 501(c)(3) nonprofit in direct response to a federal government …
MAPS Welcomes Federal Action to Advance Science-Driven Psychedelic Research and Policy
April 18, 2026
April 18, 2026 — The Multidisciplinary Association for Psychedelic Studies (MAPS) issued the following statements from Co-Executive Directors Betty Aldworth and Ismail L. Ali, J.D., on today’s Executive …
2026 First Quarter — Legislative Wrap Up
March 30, 2026
2026 is an important year for psychedelic state policy reform, reflecting the emerging evidence, creative leadership, and increasing confidence of a more mature movement. As the public deepens its understanding …
MAPS, in Partnership with the Shulgin Foundation, Launches Music Is the Bridge Video Series; First Episode Features Reggie Watts and Hamilton Morris
March 11, 2026
Lafayette, CA (March, 11, 2026) — The Multidisciplinary Association for Psychedelic Studies (MAPS), a 501(c)(3) nonprofit advancing research, education, and advocacy around psychedelics and cannabis, …
MAPS Sends Expert Delegation to United Nations Commission on Narcotic Drugs
March 9, 2026
Vienna, Austria; March 9, 2026 —The Multidisciplinary Association for Psychedelic Studies (MAPS) will send senior academics, advocates, Veterans, and policy experts to the 69th session of the United …
In a Defining Election Year, MAPS Releases Policy Guidebook to Shape the Future of Psychedelic Reform
February 5, 2026
Washington, DC; February 4, 2026 — With the United States in a pivotal election year, the Multidisciplinary Association for Psychedelic Studies (MAPS) released its Policy Guidebook, a robust resource …
MAPS and Columbia University Partner on First-of-its-Kind Study of MDMA-Assisted Couples Therapy
February 3, 2026
February 2, 2026 — The Multidisciplinary Association for Psychedelic Studies (MAPS) announces a formal research partnership with Columbia University to study how practitioners are facilitating MDMA-assisted …
MAPS Submits Protocol Amendment 4, Version 1 to FDA for MJP2 Phase 2 Study
January 30, 2026
On January 30, 2026, the Multidisciplinary Association for Psychedelic Studies (MAPS) submitted MJP2 Protocol Amendment 4, Version 1 (A4V1) to the U.S. Food and Drug Administration (FDA) for review. …
Green, Volat Transition from the MAPS Board of Directors to Committee Members
January 14, 2026
January 14, 2026 — In October 2025, Joe Green and Miriam Volat resigned their positions as members of the MAPS Board of Directors. Mr. Green joined the MAPS board in December 2020 and — among other …